Autologous transplant recipient healthy marrow. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy25

Bone Marrow Bone Marrow Cells Transplants Hematopoietic Stem Cells T-Lymphocytes Antilymphocyte Serum Kidney Cells, Cultured Spleen Lymphocytes CD4-Positive T-Lymphocytes Liver CD8-Positive T-Lymphocytes T-Lymphocytes, Cytotoxic Stromal Cells Clone Cells Dendritic Cells Blood Cells Granulocytes Leukocytes, Mononuclear Stem Cells T-Lymphocytes, Regulatory Killer Cells, Natural Thymus Gland Leukocytes

Organisms14

Cytomegalovirus BK Virus Mice, Inbred C57BL Transplantation Chimera Radiation Chimera Herpesvirus 6, Human Mice, Inbred BALB C Herpesvirus 4, Human Mice, SCID Herpesvirus 7, Human Rats, Inbred Lew Mice, Knockout Chimera Mice, Transgenic

Diseases57

Recurrence Hodgkin Disease Multiple Myeloma Cytomegalovirus Infections Postoperative Complications Opportunistic Infections Graft vs Host Disease Bronchiolitis Obliterans Bone Marrow Diseases Polyomavirus Infections Liver Failure Lymphoproliferative Disorders Kidney Failure, Chronic Mycoses Cadaver Bone Marrow Neoplasms Leukemia Acute Disease Hematologic Neoplasms Kidney Diseases Aspergillosis Infection Liver Diseases Anemia, Aplastic Viremia Lymphoma, Non-Hodgkin Delayed Graft Function Primary Graft Dysfunction Leukemia, Myeloid, Acute Renal Insufficiency Epstein-Barr Virus Infections Tumor Virus Infections Hepatitis C Chronic Disease End Stage Liver Disease Roseolovirus Infections Lymphoma Pneumonia, Viral Skin Neoplasms Herpesviridae Infections Dermatomycoses Hematologic Diseases Mucormycosis Virus Diseases Precursor Cell Lymphoblastic Leukemia-Lymphoma Zygomycosis Disease Models, Animal Myelodysplastic Syndromes Leukemia, Myeloid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Blood Group Incompatibility Neoplasms Liver Cirrhosis Nocardia Infections Lung Diseases, Fungal Gingival Hyperplasia Brain Death

Chemicals and Drugs39

Immunosuppressive Agents Cyclosporine Tacrolimus Mycophenolic Acid Ganciclovir Antilymphocyte Serum Antiviral Agents Isoantibodies HLA Antigens Sirolimus Creatinine Calcineurin Azathioprine Antifungal Agents Antibodies, Monoclonal Cyclophosphamide Antigens, CD34 Biological Markers Prednisone Busulfan DNA, Viral Melphalan Cyclosporins Granulocyte Colony-Stimulating Factor Antigens, CD Isoantigens Adrenal Cortex Hormones Immunoglobulin G Muromonab-CD3 Antibodies, Viral Carmustine Immunoglobulins, Intravenous Interferon-gamma Prednisolone Recombinant Proteins Etoposide Amphotericin B Cytokines Cytarabine

Analytical, Diagnostic and Therapeutic Techniques and Equipment93

Transplantation, Autologous Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Transplantation, Homologous Kidney Transplantation Transplantation Conditioning Treatment Outcome Hematopoietic Stem Cell Mobilization Transplantation Heart Transplantation Retrospective Studies Lung Transplantation Organ Transplantation Liver Transplantation Survival Analysis Immunosuppression Blood Transfusion, Autologous Heart-Lung Transplantation Histocompatibility Testing Follow-Up Studies Risk Factors Bone Marrow Purging Pancreas Transplantation Bone Marrow Examination Whole-Body Irradiation Prospective Studies Biopsy Stem Cell Transplantation Survival Rate Fatal Outcome Incidence Postoperative Period Polymerase Chain Reaction Flow Cytometry Combined Modality Therapy Colony-Forming Units Assay Prognosis Drug Therapy, Combination Cohort Studies Transplantation, Isogeneic Drug Monitoring Transplantation, Heterotopic Peripheral Blood Stem Cell Transplantation Glomerular Filtration Rate Multivariate Analysis Lymphocyte Activation Lymphocyte Culture Test, Mixed Cell Separation Kaplan-Meier Estimate Skin Transplantation Proportional Hazards Models Viral Load Risk Assessment Immunophenotyping Kidney Function Tests Blood Transfusion Islets of Langerhans Transplantation Lymphocyte Depletion Fetal Tissue Transplantation Monitoring, Immunologic Antineoplastic Combined Chemotherapy Protocols Leukocyte Count Cell Transplantation Remission Induction Lymphocyte Transfusion Case-Control Studies Reoperation Predictive Value of Tests Disease-Free Survival Renal Dialysis Drug Administration Schedule Cord Blood Stem Cell Transplantation Donor Selection Postoperative Care Chi-Square Distribution Sensitivity and Specificity Tissue and Organ Harvesting Patient Selection Pilot Projects Registries Tissue Transplantation Disease Models, Animal Cell Count Immunotherapy, Adoptive Blood Cell Count Platelet Count Immunohistochemistry Actuarial Analysis Enzyme-Linked Immunosorbent Assay Adoptive Transfer Salvage Therapy Feasibility Studies Coculture Techniques

Phenomena and Processes28

Graft Rejection Graft Survival Time Factors Immunocompromised Host Transplantation Immunology Histocompatibility Hematopoiesis Transplantation Tolerance Radiation Chimera Cell Differentiation Glomerular Filtration Rate Lymphocyte Activation Viral Load Immune Tolerance Leukocyte Count Cytotoxicity, Immunologic Virus Activation Dose-Response Relationship, Drug Immunity, Cellular Chi-Square Distribution Sensitivity and Specificity Cell Count Immunocompetence Blood Cell Count Platelet Count Phenotype Antibody Formation Cell Division

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Survival Rate Fatal Outcome Incidence Registries

Named Groups2

Tissue Donors Living Donors

Health Care30

Treatment Outcome Retrospective Studies Survival Analysis Follow-Up Studies Tissue and Organ Procurement Risk Factors Prospective Studies Survival Rate Waiting Lists Fatal Outcome Incidence Postoperative Period Cohort Studies Multivariate Analysis Kaplan-Meier Estimate Proportional Hazards Models Risk Assessment Age Factors Case-Control Studies Predictive Value of Tests Disease-Free Survival Donor Selection Postoperative Care Chi-Square Distribution Sensitivity and Specificity Patient Selection Pilot Projects Registries Actuarial Analysis Feasibility Studies

Geographicals2

Iran United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care Geographicals

Transplantation, Autologous Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Transplantation, Homologous Kidney Transplantation Bone Marrow Transplantation Conditioning Graft Rejection Bone Marrow Cells Treatment Outcome Hematopoietic Stem Cell Mobilization Immunosuppressive Agents Transplantation Recurrence Graft Survival Hodgkin Disease Heart Transplantation Multiple Myeloma Retrospective Studies Lung Transplantation Organ Transplantation Liver Transplantation Transplants Tissue Donors Survival Analysis Cytomegalovirus Infections Cyclosporine Tacrolimus Immunosuppression Postoperative Complications Time Factors Immunocompromised Host Mycophenolic Acid Blood Transfusion, Autologous Living Donors Transplantation Immunology Cytomegalovirus Opportunistic Infections Graft vs Host Disease Heart-Lung Transplantation BK Virus Histocompatibility Testing Hematopoietic Stem Cells Bronchiolitis Obliterans Ganciclovir Follow-Up Studies Tissue and Organ Procurement Risk Factors Bone Marrow Diseases Polyomavirus Infections Liver Failure Lymphoproliferative Disorders Kidney Failure, Chronic Bone Marrow Purging Pancreas Transplantation Mycoses Cadaver Bone Marrow Examination Whole-Body Irradiation Prospective Studies T-Lymphocytes Biopsy Antilymphocyte Serum Antiviral Agents Stem Cell Transplantation Survival Rate Waiting Lists Bone Marrow Neoplasms Isoantibodies HLA Antigens Mice, Inbred C57BL Histocompatibility Hematopoiesis Fatal Outcome Incidence Leukemia Acute Disease Kidney Postoperative Period Sirolimus Creatinine Transplantation Chimera Hematologic Neoplasms Cells, Cultured Polymerase Chain Reaction Kidney Diseases Flow Cytometry Calcineurin Aspergillosis Azathioprine Combined Modality Therapy Colony-Forming Units Assay Transplantation Tolerance Prognosis Drug Therapy, Combination Infection Antifungal Agents Liver Diseases Cohort Studies Antibodies, Monoclonal

No FAQ available that match "autologous transplant recipient healthy marrow"